STAGE IV OVARIAN CANCER AJCC V8
Clinical trials for STAGE IV OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemotherapy mist shows promise in targeting stomach, ovarian, and colon cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of a new method called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. The study includes adults with ovarian, uterine, appendix, stomach, or colorectal canc…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 16, 2026 22:51 UTC
-
New hope for tough ovarian cancers: PLX038 trial targets Drug-Resistant tumors
Disease control Recruiting nowThis study tests a drug called PLX038 in people with ovarian, fallopian tube, or peritoneal cancer that has spread and no longer responds to platinum chemotherapy. The goal is to see if PLX038 can shrink tumors by blocking enzymes cancer cells need to grow. About 43 adults with a…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 16, 2026 22:49 UTC
-
Less invasive surgery may help ovarian cancer patients recover faster
Disease control Recruiting nowThis study tests if a less invasive surgery (laparoscopy) works as well as standard open surgery for people with advanced ovarian, fallopian tube, or peritoneal cancer who have already had chemotherapy. About 580 participants will be randomly assigned to one of the two surgeries.…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New hope for recurrent gynecologic cancers: Drug-Radiation combo enters human testing
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancers (ovarian, endometrial, cervical, and others) have returned after prior treatment. The goal is to find the safest dose and see if the combination can shrink …
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New hope for Hard-to-Treat cancers: targeted pill shows promise in DNA-Repair defect tumors
Disease control Recruiting nowThis study is testing a daily pill called talazoparib in people with advanced solid tumors (like breast, prostate, ovarian, or pancreatic cancer) that have specific DNA repair gene mutations. The drug works by blocking a protein that helps cancer cells fix their DNA, causing them…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Heated chemotherapy during surgery: a new hope for ovarian cancer?
Disease control Recruiting nowThis study tests the safety of giving heated chemotherapy directly into the abdomen during surgery for advanced ovarian, fallopian tube, or peritoneal cancer. About 45 participants will receive either heated chemo during surgery or standard chemo before surgery. The goal is to se…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Electric field device joins forces with cancer drugs in early trial
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to find …
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New drug combo trial hopes to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like certain melanomas, ovarian, or uterine cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will ta…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
Could a simple wash catch ovarian cancer before it spreads?
Diagnosis Recruiting nowThis study is testing whether a combination of DNA from a uterine wash and proteins from a blood sample can accurately detect ovarian cancer. Researchers will collect these samples from 250 women before surgery for suspected ovarian cancer or as a preventive measure. The goal is …
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 08, 2026 13:12 UTC
-
Smartwatch study aims to get cancer patients moving for better health
Symptom relief Recruiting nowThis study tests whether a personalized activity program using a Fitbit can help women with advanced ovarian or endometrial cancer exercise more and improve their quality of life. About 120 participants will either get standard care or a tailored plan with activity goals and feed…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 11, 2026 12:08 UTC
-
Could probiotics ease chemo side effects in ovarian cancer?
Symptom relief Recruiting nowThis study tests whether taking probiotics (healthy bacteria supplements) can improve gut and vaginal health in 161 people with advanced or recurrent ovarian cancer who are receiving platinum chemotherapy. Participants will take either probiotic pills or a placebo, and researcher…
Matched conditions: STAGE IV OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 27, 2026 23:05 UTC